NVC-001 is designed to target the mechanobiological root cause of LMNA dilated cardiomyopathy and has disease-modifying potential SINGAPORE, PARIS and PHILADELPHIA, Oct. 8, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes of life-threatening cardiomyopathies, today announced that the first...
SINGAPORE, Aug. 15, 2025 /PRNewswire/ -- 51Talk Online Education Group (NYSE American: COE) announced Mr. David Chung, the Company's Investor Relations Vice President, will present...
QINGDAO, China, Aug. 15, 2025 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, has officially launched the Hisense TriChroma...
BEIJING, Aug. 15, 2025 /PRNewswire/ -- By seizing the opportunity of China's visa-free policy for the Republic of Korea (ROK), the Weihai Economic and...